🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Making the Most of Health Data to Deliver Pharmaceutical Innovation: What Are the Legal Barriers? (Guest blog) efpia.eu/news-events/th… via EFPIA

Today we launch new research with @GM_HSC Office of Health Economics RAND Europe & King's College London into how outcome-based payment for some cancer drugs could speed up patient access to new treatment options in England. Read our findings here: po.st/iEL5Ox

As I take a brief "break" from my maternity leave to attend ISPOR, I'm super impressed with the nursing room provided. Bravo #ISPOREurope #WomeninHEOR

Come and see me at poster location H4 to talk about indication based pricing...can we? should we? #ISPOREurope Office of Health Economics

LAUNCHING TODAY: In response to the 'new normal' of remote working and the challenges it's presenting, OHE is pleased to announce a new programme of virtual events and blogs. We're kicking off with a free Paying for Cures Webinar on 26 May at 15:00 GMT eventbrite.co.uk/e/paying-for-c…

OHE Consulting report published today outlines stakeholders’ thoughts around the positives, pitfalls and practicalities of indication-based pricing of medicines. ohe.org/news/indicatio…

Why not follow OHE's Twitter page for snippets of insight on our latest research: x.com/OHENews

The science underlying medicine development is evolving. So too must our payment models, or we risk missing out on the full potential of medical innovation. Read our new report, developed in collaboration with AstraZeneca, to find out why ohe.org/news/do-multip… #Health #Pricing

Can value-based pricing at indication-level support better patient access and value whilst protecting financial sustainability of payers? Join Amanda Cole 30 Nov 1pm CET #ISPOREurope to learn what it takes. ⁦(@marghineri⁩ ⁦Graham Cookson⁩) ispor.org/heor-resources…

Last year we convened 16 experts from 11 countries to develop a consensus and recommendations on multi-indication payment models. Results now presented at #ISPOREurope Spoiler: data systems are key! Hear more from us on Nov 30, 1pm and check this out👇 ispor.org/heor-resources…

Innovation in medicine takes many forms. Learn how value-based pricing for medicines used across #cancer types & treatment regimens can optimise access for patients, and incentivise drug development, in a new report in collaboration with @OHENEWS: know.az/3og2b52

We’ve worked on this with Office of Health Economics and RAND Europe. You can read their blog here: bit.ly/3DevOYJ Read our own blog here: bit.ly/3IcAyBT

OHE’s Adrian Towse recently moderated an ISPOR panel, in which the panelists discussed whether current HTA methods are fit for purpose when assessing gene therapies. Read our summary here: ohe.org/news/ispor-iss… #HealthEconomics #Economics #Research #HealthCare #Health #HTA

Payment models must keep pace with science, or we risk missing out on the full potential of medical innovation. Join our next free-to-attend Masterclass on 22 June, organised and funded by AstraZeneca, to find out why hubs.la/Q01d5mT50 #HealthEconomics #HealthPolicy #Health

How to collaborate on access solutions to unlock the potential of multi-indication therapies? See highlights from our OHE Masterclass, organised and funded by AstraZeneca. hubs.ly/Q01qKlpZ0 #HealthEconomics #HTA #HealthPolicy #HealthCare #Health

💡Launched at #ISPORAnnual💡 Office of Health Economics's new free Educational Program, developed with PhRMA support, explains the key provisions in the Inflation Reduction Act (IRA) related to payment and coverage. Register now: ohecourseinflationreductionact.com

Fantastic ISPOR #ISPORAnnual discussion w/Office of Health Economics @SchaefferCenter Peter Kolchinsky & Gunnar Esiason on ways to improve U.S. CBO Rx innovation models. #AffordableInnovation

We ❤️ simplification! @LotteSteuten giving us a Masterclass in a GRACE-ful solution to the problem of accounting for severity in HTA #ISPORAnnual

A complicated journey with lots of love and cuddles ❤️ Amanda and Rich Cole describe life with Ben, who has the rare genetic disorder Malan syndrome. Our Rare Diseases Action Plan is improving care, treatment and research for rare conditions. #RareDiseaseDay Genetic Alliance UK